Insight Molecular Diagnostics Inc.
IMDXUS売上高
$4M
百万USD
営業利益
$-51M
百万USD
純利益
$-50M
百万USD
ROE
159.6%
最新FY
EPS
$-1.65
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $1M | $-4M | - |
| FY2021 | Q2 | $2M | $-10M | - |
| FY2021 | Q3 | $1M | $-14M | - |
| FY2021 | FY | $8M | $-64M | - |
| FY2022 | Q1 | $1M | $-10M | - |
| FY2022 | Q2 | $2M | $-8M | - |
| FY2022 | Q3 | $1M | $-9M | - |
| FY2022 | FY | $1M | $-73M | - |
| FY2023 | Q1 | $0M | $3M | $0.02 |
| FY2023 | Q2 | $0M | $-8M | $-1.07 |
| FY2023 | Q3 | $0M | $-6M | $-0.81 |
| FY2023 | FY | $2M | $-28M | $-3.75 |
| FY2024 | Q1 | $0M | $-9M | $-1.13 |
| FY2024 | Q2 | $0M | $-5M | $-0.36 |
| FY2024 | Q3 | $0M | $-13M | $-0.98 |
| FY2024 | FY | $2M | $-61M | $-4.66 |
| FY2025 | Q1 | $2M | $-7M | $-0.26 |
| FY2025 | Q2 | $1M | $-10M | $-0.30 |
| FY2025 | Q3 | $0M | $-11M | $-0.34 |
| FY2025 | FY | $4M | $-50M | $-1.65 |
| FY2026 | Q1 | $0M | $-4M | $-0.12 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | $1M | $8M | $1M | $2M | $2M | $4M |
| 営業利益 | $-11M | $-19M | $-15M | $-22M | $-30M | $-74M | $-18M | $-25M | $-61M | $-51M |
| 純利益 | $-11M | $-19M | $-16M | $-22M | $-30M | $-64M | $-73M | $-28M | $-61M | $-50M |
| 総資産 | $14M | $10M | $10M | $40M | $55M | $160M | $100M | $75M | $35M | $26M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $10M | $4M | $3M | $31M | $33M | $65M | $34M | $20M | $-12M | $-31M |
| 営業CF | - | $-13M | $-12M | $-20M | $-26M | $-36M | $-46M | $-23M | $-21M | $-22M |
| EPS | - | - | - | - | - | - | - | $-3.75 | $-4.66 | $-1.65 |
| BPS | $0.34 | $0.14 | $0.07 | $0.49 | $0.38 | $0.55 | $0.21 | $2.47 | $-0.43 | $-0.98 |
| ROE | -113.2% | -440.0% | -460.2% | -72.7% | -89.4% | -98.3% | -212.6% | -135.7% | 494.2% | 159.6% |